No insider purchases or sales are on record for OptimizeRx Corp in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 50 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $109.4M | $92.1M | $71.5M | $62.5M |
| GROSS PROFIT | $73.6M | $59.4M | $42.9M | $39.0M |
| OPERATING INCOME | $11.7M | $-13.7M | $-26.4M | $-12.3M |
| NET INCOME | $5.1M | $-20.1M | $-17.6M | $-11.4M |
| EPS (DILUTED) | 0.27 | -1.10 | -1.03 | -0.64 |
| OPERATING CASH FLOW | $18.7M | $4.9M | $-7.2M | $10.7M |
| CASH | $23.4M | $13.4M | $13.9M | $18.2M |
| LONG-TERM DEBT | $21.4M | $30.8M | $34.2M | — |
| BUYBACKS | — | — | $7.5M | $20.0M |
No password to create and no card required. We store your email address and nothing else.